Markets

Insider Trading

Hedge Funds

Retirement

Opinion

In the face of the China-Taiwan conflict, our national health security is threatened

​As China reaffirms the threat of military force to take Taiwan, the whole world has caught its breath and is closely following the course of events.

Taiwan has a total of 55 out of 58 pharma manufacturing companies that are domestically owned and manufacture high value API (Active Pharmaceutical Ingredients) biologics and injectables.

China is a major supplier of a variety of intermediate goods for manufacturing, including APIs, used to produce generic drugs that make up 90% of the medicines Americans take. These are prescription and over the counter medications that are distributed to U.S. hospitals, sold in corner drug stores, grocery store pharmacies, and distributed to military hospitals and clinics.

Outsourcing our drug supply comes at a cost. Over the past decade China has taken over and now dominates the global pharmaceutical industry. The zero covid policy that China imposed earlier this year, resulting in over 70 cities being placed in lockdown and impacting over 300 million people has no end in sight. China leads the list on total volume of pharmaceuticals imported to the US, along with India and Mexico coming in second and third respectively.

The US has virtually zero production capacity when it comes to most of our most common and important medications. In the face of the China-Taiwan conflict, our national health security is threatened.

What can we do to prepare for how this could impact medication availability?

​As the world continues to grapple with the seemingly endless attacks on our supply chain, medical preparation is of paramount importance. We have entered a new era of uncertainty many of us have been ill prepared to deal with.

It is now time to take control of our life, and the lives of those whom we care for.

JASE Medical, a telemedicine service, is on a mission to help every family in America prepare medically. The company was founded in 2021, by Shawn Rowland M.D., who during the pandemic experienced firsthand how timely access to medical care and treatment is lacking in our country.

“Prior to the pandemic, I was working in a mid-sized community hospital and every week we would receive a briefing on which medications were in short supply. At the time, I was surprised that in our sophisticated and advanced health care system we would be dealing with shortages of some really important antibiotics and other medications. That led me to do some research and what I found was very concerning.” – said Rowland. “Pre covid most of us in the US felt like we could get whatever we needed when we needed it. But now we know all too well, when the unexpected happens it’s too late to prepare. It doesn’t take much to disrupt and even stall access to life essentials.”

The Jase Case: Providing resilience in this era of uncertainty 


Backed by board certified physicians and pharmacists, Jase Medical has put together a convenient, easy to use set of 5 antibiotics that cover a wide variety of common illnesses.

This one-of-a-kind online service provides medical preparedness to U.S. and Canadian residents (and soon also Australian) making sure they have access to life-saving medications to care for themselves and their loved ones during the unexpected. Through a quick and easy online consultation with a board-certified doctor, you can obtain a long-term supply of emergency antibiotics to treat the most common as well as most deadly bacterial infections.

The Jase case contains 5 lifesaving antibiotics, equipped to handle infections ranging from

  • Travelers diarrhea,
  • Wound infections,
  • Prophylactic management of lymes disease from a tick bite
  • Bioterror events,
  • Bladder infections
  • Strep throat
  • Ear infections
  • And many more

The convenient, easy to read booklet guides you through the process of knowing when and if an antibiotic is indicated.  If you have questions regarding the use of any of the antibiotics, you can send a message to the on-call physician for treatment related questions.

Jase Medical is in the process of adding more medications to their formulary and will be announcing these as they become available.


AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 75%.

For a ridiculously low price of just $24, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

  • The Name of the Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.
  • Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.
  • Lifetime Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund ANYTIME, no questions asked.

 

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

  1. Head over to our website and subscribe to our Premium Readership Newsletter for just $24.
  2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.
  3. Sit back, relax, and know that you’re backed by our ironclad lifetime money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Subscribe Now!

Google CEO: This Will Be Bigger Than Electricity

I work for one of the largest independent financial publishers in the world – representing over 1 million people in 148 countries.

We’re independently funding today’s broadcast to address something on the mind of every investor in America right now…

Should I put my money in Artificial Intelligence?

Here to answer that for us… and give away his No. 1 free AI recommendation… is 50-year Wall Street titan, Marc Chaikin.

Marc’s been a trader, stockbroker, and analyst. He was the head of the options department at a major brokerage firm and is a sought-after expert for CNBC, Fox Business, Barron’s, and Yahoo! Finance…

But what Marc’s most known for is his award-winning stock-rating system. Which determines whether a stock could shoot sky-high in the next three to six months… or come crashing down.

That’s why Marc’s work appears in every Bloomberg and Reuters terminal on the planet…

And is still used by hundreds of banks, hedge funds, and brokerages to track the billions of dollars flowing in and out of stocks each day.

He’s used this system to survive nine bear markets… create three new indices for the Nasdaq… and even predict the brutal bear market of 2022, 90 days in advance.

Click to continue reading…